Ruconest

Tjoapack Netherlands BV🇺🇸 United States

FDA Page

Effective Date: Oct 24, 2022
Approval ID: 3cf4c3f5-5230-277e-e054-00144ff8d46c
Products: 1 registered
Version: 18

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RUCONEST safely and effectively. See full prescribing information for RUCONEST. RUCONEST (C1 esterase inhibitor [recombinant]) For Intravenous Use, Lyophilized Powder For Reconstitution Initial U.S. Approval: 2014

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.